In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

In a report released on January 21, Brian Abrahams from RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research ...

Orna Therapeutics and Shanghai Simnova expand their collaboration to develop RNA-based therapies targeting BCMA for multiple ...

Orna Therapeutics, Inc. ("Orna") and Shanghai Simnova Biotech Co., Ltd. ("Simnova") are pleased to announce the expansion of their strategic collaboration to include BCMA (B-cell maturation antigen) ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

OMNY Health is partnering with Scipher Medicine. Vertex Pharmaceuticals signed a three-year deal with Orna Therapeutics to use the RNA biotech’s delivery particles to develop its next iteration of ...

Analyst Charles Zhu from LifeSci Capital maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report) and keeping the price target at $8.00. Discover outperforming stocks and invest ...

(RTTNews) - Spero Therapeutics, Inc. (SPRO), said on Friday that following a Wells Notice from the Securities and Exchange Commission, or SEC, related to certain public disclosures made in 2022 ...

Keros Therapeutics announced updates to its corporate presentation, highlighting ongoing and future clinical trials for its product candidates, including cibotercept (KER-012) for pulmonary ...

Intellia Therapeutics announced a strategic restructuring to focus on its late-stage programs, NTLA-2002 for HAE and nexiguran ziclumeran for ATTR amyloidosis, which includes a 27% reduction in ...

Y-mAbs Therapeutics (YMAB) announced the appointment of Doug Gentilcore as Senior Vice President SVP, Head of DANYELZA Business Unit. Prior to joining Y-mAbs, he served as Chief Commercial Officer ...